Purchase Order N3239822P0309
Award Date 8/29/22
Potential Completion Date 8/29/25
Potential Value $125K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $80,778.39 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for CAT# MS-102-3003 MISEQ sequencing systems and associated items. The contract has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing various sequencing platforms and consumables to support genomics research and diagnostic...
- This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Illumina, Inc., a manufacturer of genomic sequencing instrumentation and reagents. The $153,192.00 contract is for the provision of a MiSeq Silver sequencing system and associated products to support the agency's nucleic acid sequencing needs, specifically to characterize biological threats at the Naval Medical Research Center's Biological Defense Research...
- This is a firm-fixed-price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of one MiSeq System and a 12-month MiSeq Silver Support Plan, valued at $88,357.50. The contract was awarded on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), as the Naval Health Research Center requires Illumina's proprietary MiSeq technology for their...
- This federal contract award to Illumina, Inc. is a purchase order (PO) for a MiSeq System, a genomic sequencing instrument, valued at $95,931.00. The award was made by the U.S. Navy Bureau of Medicine and Surgery (BUMED) and is not associated with a set-aside program. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing these products and related services to various federal agencies, including the National Institutes of Health (NIH),...
- This federal contract award, valued at $89,232.71, was issued by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc. Illumina, a manufacturer of genomic sequencing instruments and reagents, is providing health check services for BUMED's MiSeq and NextSeq 500 sequencing systems under this firm fixed price purchase order. The award is not associated with a larger contract vehicle and does not have a set-aside designation. Illumina has previously supported genomic research and...
- This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for $97,678.20. The award provides Illumina's RNA sequencing products and reagents to support the Naval Health Research Center's (NHRC) laboratory work characterizing biological threats. The contract has a period of performance through December 1, 2021. This award is not associated with a set-aside program. Illumina has previously...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract, valued at $80,858.46, is for the delivery of various Illumina sequencing systems, reagents, and consumables to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This award is made under an...
- This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command to Illumina, Inc. to provide a MiSeq DNA Sequencer for $111,782.23. The contract has no set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided various sequencing systems, reagents, and services to support research and diagnostics across multiple federal agencies. This award is likely part of Illumina's...
- The Bureau of Medicine and Surgery (BUMED) awarded a $12,990.38 firm fixed-price purchase order to Illumina, Inc. on November 11, 2025, for specialized molecular biology reagents and diagnostic kits with an ultimate completion date of February 6, 2026. The contract covers a MiSeq Reagent Nano Kit V2 (300-cycles) and an Illumina Respiratory Virus Enrichment Kit Set A, both critical components for next-generation sequencing applications. Performance will take place in San Diego, California,...
- This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command (NAVSEA), a Defense agency, to Illumina, Inc. The contract has a ceiling value of $69,157.00 and a completion date of August 26, 2021. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing goods and services to support NAVSEA's nucleic acid sequencing needs, including reagents and controls for MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms used at...